\-\ Texto\\:\\ \ \(0\)\
\-\ multiple\\ cranial\\ nerve\\ deficits\ \(1\)\
\-\ radiation\\ and\\ chemotherapy\ \(19\)\
\-\ \\â\\€\\¢\\ butterfly\\ spread\\ of\\ tumor\\ from\\ right\\ frontal\\ lobe\\ across\\ corpus\\ callosum\\ into\\ left\\ frontal\\ lobe\\.\ \(0\)\
\-\ \\â\\€\\¢\\ diffuse\\ enhancement\\ of\\ leptomeningeal\\ surfaces\\ following\\ contrast\\ admnistration\\.\ \(0\)\
\-\ gbm\\ \\(glioblastoma\\ multiforme\\)\\ with\\ leptomeningeal\\ carcinomatosis\ \(0\)\
\-\ \\â\\€\\¢\\ meningitis\\,\\ infectious\ \(0\)\
\-\ \\â\\€\\¢\\ recurrent\\ subarachnoid\\ hemorrhage\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ sarcoidosis\ \(1\)\
\-\ \\â\\€\\¢\\ meningitis\\,\\ carcinomatous\ \(0\)\
\-\ 65\\ year\\ old\\ woman\\ with\\ headache\\ and\\ multiple\\ cranial\\ nerve\\ deficits\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.1567014351595888\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.1450813944480894\ \(0\)\
\-\ meningitis\\:\\ 0\\.12667119397978904\ \(0\)\
\-\ admnistration\\:\\ 0\\.1259359774852357\ \(0\)\
\-\ deficits\\:\\ 0\\.11172124701508768\ \(0\)\
\-\ cranial\\:\\ 0\\.1061614856040657\ \(0\)\
\-\ carcinomatous\\:\\ 0\\.09813726107015978\ \(0\)\
\-\ butterfly\\:\\ 0\\.09043731105969281\ \(0\)\
\-\ nerve\\:\\ 0\\.08796988932820875\ \(0\)\
\-\ surfaces\\:\\ 0\\.07939174122778593\ \(0\)\
\-\ frontal\\:\\ 0\\.07669405527095306\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.07474284979300555\ \(0\)\
\-\ gbm\\:\\ 0\\.07220454726104193\ \(0\)\
\-\ multiforme\\:\\ 0\\.07093386888937771\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.06720920799704552\ \(0\)\
\-\ lobe\\:\\ 0\\.0656950099406724\ \(0\)\
\-\ across\\:\\ 0\\.06524318831310198\ \(0\)\
\-\ callosum\\:\\ 0\\.06263859464461691\ \(0\)\
\-\ corpus\\:\\ 0\\.06014783197112009\ \(0\)\
\-\ 65\\:\\ 0\\.059587536068930365\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.05931541899792045\ \(0\)\
\-\ spread\\:\\ 0\\.05904838852631826\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.05513844809093196\ \(0\)\
\-\ infectious\\:\\ 0\\.05248364096376911\ \(0\)\
\-\ recurrent\\:\\ 0\\.051514746730358246\ \(0\)\
\-\ multiple\\:\\ 0\\.05142302867083625\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.043756368359155216\ \(0\)\
\-\ headache\\:\\ 0\\.041928363393797116\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.040632236916800506\ \(0\)\
\-\ radiation\\:\\ 0\\.040060732136604806\ \(0\)\
\-\ diffuse\\:\\ 0\\.036957248862504496\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0348885519198498\ \(0\)\
\-\ following\\:\\ 0\\.03464682509858783\ \(0\)\
\-\ enhancement\\:\\ 0\\.032721268087471944\ \(0\)\
\-\ into\\:\\ 0\\.029047519542281526\ \(0\)\
\-\ tumor\\:\\ 0\\.028460461451583017\ \(0\)\
\-\ woman\\:\\ 0\\.028198613535555802\ \(0\)\
\-\ contrast\\:\\ 0\\.027325366954398647\ \(0\)\
\-\ from\\:\\ 0\\.01809193875934589\ \(0\)\
\-\ left\\:\\ 0\\.013658646703898781\ \(0\)\
\-\ year\\:\\ 0\\.013658646703898781\ \(0\)\
\-\ right\\:\\ 0\\.012880452987291666\ \(0\)\
\-\ old\\:\\ 0\\.01249906566946078\ \(0\)\
\-\ \\(\\:\\ 0\\.01031945323205515\ \(0\)\
\-\ \\)\\:\\ 0\\.010193395601618643\ \(0\)\
\-\ \\,\\:\\ 0\\.007734573300493925\ \(0\)\
\-\ and\\:\\ 0\\.005143114449491956\ \(0\)\
\-\ with\\:\\ 0\\.003342976459711135\ \(0\)\
\-\ of\\:\\ 0\\.0033286800227996694\ \(0\)\
\-\ \\.\\:\\ 0\\.001521408689886269\ \(0\)\
